MAPT and tauopathy: Inactivating mutant tau from 13 weeks of age by administering DOX produced significant protection against the changes in sleep architecture, sleep continuity and behaviour in the Tg group, providing evidence that the genome disruptions proposed by [34] do not create the full biological tauopathy phenotype.